Clinicopathologic Characteristics of CD99-Positive Diffuse Large B-Cell Lymphoma

  • Lee, Sang Pyo; 
  • Park, Sanghui; 
  • Park, Jinny; 
  • Hong, Junshik; 
  • Ko, Young Hyeh
Citations

WEB OF SCIENCE

10
Citations

SCOPUS

12

초록

Background: CD99 immunoreactivity has been documented in a variety of tumors, including lymphoid malignancies such as anaplastic large-cell lymphomas. However, few studies have investigated the prognostic impact of CD99 in diffuse large B-cell lymphoma (DLBCL). Methods: Using conventional paraffin embedding, immunoperoxidase staining and tissue microarrays, we retrospectively investigated CD99 expression in 155 DLBCL patients. Results: Of the 155 DLBCL patients, 60 (38.7%) were positive for CD99. CD99 positivity was significantly associated with advanced stage (p < 0.01), higher risk group according to the International Prognostic Index risk score (p < 0.01) and non-germinal center B cell-like type (p = 0.01). The difference in progression-free survival (PFS) between CD99+ and CD99- groups was statistically significant (p = 0.04), even though the difference in overall survival was not (p = 0.74). Multivariate analysis demonstrated that CD99 expression was marginally correlated with PFS. Conclusion: To the best of our knowledge, this is the first report on the clinicopathologic characteristics of CD99+ DLBCL, particularly unique clinicopathologic features. Copyright (C) 2010 S. Karger AG, Basel

키워드

Anaplastic carcinomas; CD99; Diffuse large B-cell carcinomas; Germinal center B cells; Lymphomas; CORD-STROMAL TUMORS; FREQUENT EXPRESSION; SYNOVIAL SARCOMA; CD99 EXPRESSION; INHIBIN-ALPHA; IMMUNOREACTIVITY; CARCINOMAS; TISSUE
제목
Clinicopathologic Characteristics of CD99-Positive Diffuse Large B-Cell Lymphoma
저자
Lee, Sang Pyo; Park, Sanghui; Park, Jinny; Hong, Junshik; Ko, Young Hyeh
DOI
10.1159/000322551
발행일
2011-03
유형
Article
저널명
Acta Haematologica
권
125
호
3
페이지
167 ~ 174